It will also be interesting to further explore whether an earlier onset of the ischaemic strokes in the three NOTCH3 null patients identified thus far, as compared with CADASIL patients, is a consistent feature and may reflect more dramatic vascular aberrations. This evidence concerns the gene NOTCH3 and ischemic stroke.